RESUMO
Lipids are important molecules for human health. The quantity and quality of fats consumed in the diet have important effects on the modulation of both the natural biosynthesis and degradation of lipids. There is an important number of lipid-failed associated metabolic diseases and an increasing number of studies suggesting that certain types of lipids might be beneficial to the treatment of many metabolic diseases. The aim of the present work is to expose an overview of de novo biosynthesis, storage, and degradation of lipids in mammalian cells, as well as, to review the published data describing the beneficial effects of these processes and the potential of some dietary lipids to improve metabolic diseases.
Assuntos
Tecido Adiposo/metabolismo , Gorduras na Dieta , Metabolismo dos Lipídeos , Doenças Metabólicas/metabolismo , Animais , Biomarcadores/metabolismo , Colesterol/metabolismo , Dieta , Eicosanoides/metabolismo , GTP Fosfo-Hidrolases/metabolismo , Homeostase , Humanos , Proteínas Mitocondriais/metabolismo , Fosfolipídeos/metabolismo , Esteróis/metabolismo , Triglicerídeos/metabolismoRESUMO
We report a de novo aleukemic form of MCL with a complex monosomic karyotype with LOH for multiple chromosomes and TP53 mutation. Additionally, whereas D816V KIT was not found, the c-Kit transmembrane domain p.M541L variant was detected which is the most common SNP of KIT gene in humans with controversial pathogenic role. In these cases, it is crucial to perform a rapid broad molecular study for an accurate diagnosis which could help to initiate targeted therapy.